DEXRAZOXANE FOR INJECTION

DEXRAZOXANE FOR INJECTION was reported 944 times

DEXRAZOXANE FOR INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CEREBRAL CANDIDIASIS 11 0.7333
1 GLUTATHIONE REDUCTASE ACTIVITY INCREASED 1 0.3333
2 URINARY SYSTEM X-RAY 1 0.3333
3 BURKITT'S LYMPHOMA STAGE III 1 0.1250
4 ACUTE LYMPHOCYTIC LEUKAEMIA (IN REMISSION) 2 0.1053
5 STOMATOCOCCAL INFECTION 12 0.0968
6 RHABDOID TUMOUR 5 0.0962
7 PRIMITIVE NEUROECTODERMAL TUMOUR 5 0.0926
8 BURKITT'S LEUKAEMIA 1 0.0909
9 LYMPHOID TISSUE HYPOPLASIA 11 0.0719
10 THYMUS HYPOPLASIA 10 0.0575
11 LIPOSARCOMA METASTATIC 1 0.0435
12 RESPIRATORY MONILIASIS 11 0.0410
13 PYOMYOSITIS 12 0.0405
14 ENDOMETRIAL STROMAL SARCOMA 2 0.0400
15 BURKITT'S LYMPHOMA 4 0.0381
16 OSTEOSARCOMA METASTATIC 3 0.0316
17 OSTEOSARCOMA 12 0.0312
18 CUTANEOUS MUCORMYCOSIS 5 0.0272
19 HUMAN HERPESVIRUS 6 VIRAEMIA 1 0.0250
20 DISSEMINATED ASPERGILLOSIS 11 0.0233
21 BILE ACIDS INCREASED 4 0.0226
22 SKIN CANDIDA 11 0.0211
23 JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0196
24 SEROCONVERSION TEST POSITIVE 1 0.0189
25 TROPONIN 1 0.0179
26 PERONEAL NERVE INJURY 2 0.0177
27 RETINOIC ACID SYNDROME 3 0.0174
28 BLOOD BETA-D-GLUCAN INCREASED 5 0.0163
29 LUNG ASSIST DEVICE THERAPY 1 0.0161
30 FLAGELLATE DERMATITIS 1 0.0154
31 INFANTILE VOMITING 3 0.0152
32 INFANTILE DIARRHOEA 1 0.0152
33 PLATELETCRIT DECREASED 1 0.0133
34 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE ABNORMAL 1 0.0128
35 AMMONIA DECREASED 1 0.0128
36 CHONDROSARCOMA 2 0.0127
37 BREAST INJURY 2 0.0123
38 INFECTIVE MYOSITIS 2 0.0120
39 MYELOID LEUKAEMIA 6 0.0120
40 BONE SARCOMA 2 0.0103
41 BACILLUS TEST POSITIVE 1 0.0101
42 NASAL VESTIBULITIS 1 0.0100
43 OUT OF SPECIFICATION TEST RESULTS 1 0.0100
44 ENTEROBACTER BACTERAEMIA 3 0.0099
45 NEUROBLASTOMA RECURRENT 2 0.0099
46 CHORDOMA 1 0.0097
47 PARAINFLUENZA VIRUS INFECTION 1 0.0097
48 MYCOBACTERIUM CHELONAE INFECTION 7 0.0095
49 ANORECTAL POLYP 1 0.0093
50 PERIPORTAL OEDEMA 1 0.0080
51 PSEUDOMONAL SEPSIS 14 0.0080
52 NEPHROBLASTOMA 1 0.0079
53 AZOOSPERMIA 3 0.0078
54 HEART FAILURE WITH REDUCED EJECTION FRACTION 4 0.0075
55 HORMONE RECEPTOR POSITIVE BREAST CANCER 2 0.0074
56 ANTITHROMBIN III DECREASED 2 0.0073
57 RED BLOOD CELL TRANSFUSION 3 0.0073
58 PH BODY FLUID ABNORMAL 1 0.0072
59 LEUKAEMIC INFILTRATION 1 0.0071
60 OROPHARYNGEAL ERYTHEMA 1 0.0068
61 RADIATION MUCOSITIS 1 0.0062
62 QUADRIPARESIS 10 0.0060
63 OSTEOMYELITIS FUNGAL 1 0.0060
64 SECONDARY IMMUNODEFICIENCY 7 0.0058
65 PERICARDIAL EFFUSION MALIGNANT 1 0.0056
66 BASE EXCESS DECREASED 1 0.0056
67 CANDIDA SEPSIS 5 0.0056
68 SYSTEMIC CANDIDA 14 0.0056
69 ACUTE MONOCYTIC LEUKAEMIA 1 0.0055
70 MEDIASTINAL DISORDER 2 0.0053
71 RHABDOMYOSARCOMA 1 0.0053
72 LARYNGEAL INFLAMMATION 1 0.0053
73 EYE INFECTION FUNGAL 2 0.0052
74 EOSINOPHIL PERCENTAGE DECREASED 1 0.0050
75 ADMINISTRATION SITE EXTRAVASATION 5 0.0050
76 GRANULOCYTES ABNORMAL 1 0.0050
77 TREATMENT RELATED SECONDARY MALIGNANCY 1 0.0049
78 COLONY STIMULATING FACTOR THERAPY 1 0.0048
79 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 1 0.0047
80 COMPLICATIONS OF TRANSPLANTED HEART 1 0.0047
81 RETICULOCYTE COUNT DECREASED 2 0.0046
82 CARDIAC MYXOMA 1 0.0046
83 PNEUMOCOCCAL SEPSIS 3 0.0046
84 EPSTEIN-BARR VIRAEMIA 5 0.0045
85 NEUTROPENIA NEONATAL 1 0.0045
86 ACID BASE BALANCE ABNORMAL 1 0.0045
87 CAECITIS 2 0.0044
88 URINARY OCCULT BLOOD POSITIVE 1 0.0043
89 PERIPHERAL VEIN THROMBOSIS 1 0.0042
90 APPENDICEAL ABSCESS 1 0.0041
91 ACUTE MYELOMONOCYTIC LEUKAEMIA 1 0.0040
92 BETA 2 MICROGLOBULIN INCREASED 1 0.0038
93 CARDIOTOXICITY 34 0.0038
94 ENTEROCOCCAL BACTERAEMIA 4 0.0038
95 STREPTOCOCCAL BACTERAEMIA 4 0.0037
96 BLOOD CHOLINESTERASE DECREASED 1 0.0036
97 APLASTIC ANAEMIA 18 0.0034
98 PROCALCITONIN INCREASED 4 0.0034
99 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 6 0.0034
100 NAIL TOXICITY 1 0.0033
101 ERYTHROPENIA 1 0.0033
102 STAPHYLOCOCCAL BACTERAEMIA 14 0.0032
103 PNEUMOCYSTIS JIROVECI PNEUMONIA 7 0.0031
104 CONDUCTIVE DEAFNESS 1 0.0031
105 COLORECTAL ADENOMA 1 0.0031
106 PERITONEAL DISORDER 2 0.0031
107 HYPERMAGNESAEMIA 2 0.0031
108 ARACHNOIDITIS 2 0.0029
109 METASTASES TO CHEST WALL 1 0.0029
110 FUNGAL TEST POSITIVE 1 0.0028
111 FANCONI SYNDROME 4 0.0028
112 HODGKIN'S DISEASE 2 0.0028
113 ABSCESS BACTERIAL 1 0.0028
114 AXILLARY VEIN THROMBOSIS 1 0.0027
115 BLOOD FIBRINOGEN DECREASED 3 0.0026
116 RADIATION OESOPHAGITIS 1 0.0026
117 NEUROBLASTOMA 1 0.0026
118 CYSTITIS VIRAL 1 0.0026
119 CAPILLARY DISORDER 1 0.0026
120 INTRACRANIAL TUMOUR HAEMORRHAGE 1 0.0026
121 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 2 0.0026
122 LABORATORY TEST INTERFERENCE 2 0.0025
123 ABDOMINAL SYMPTOM 2 0.0025
124 CYTOMEGALOVIRUS VIRAEMIA 11 0.0025
125 OROPHARYNGEAL PLAQUE 1 0.0025
126 INVASIVE BREAST CARCINOMA 1 0.0024
127 VENOOCCLUSIVE DISEASE 6 0.0024
128 TROPONIN T INCREASED 3 0.0024
129 PLATELET TRANSFUSION 3 0.0023
130 DEVICE LOOSENING 2 0.0023
131 AXONAL NEUROPATHY 2 0.0023
132 PERIPHERAL NERVE INJURY 2 0.0023
133 PNEUMATOSIS 1 0.0022
134 CYSTITIS HAEMORRHAGIC 9 0.0022
135 GRANULOCYTE COUNT DECREASED 4 0.0022
136 FEBRILE NEUTROPENIA 143 0.0022
137 SKIN GRAFT 2 0.0022
138 NEUTROPENIC INFECTION 2 0.0021
139 BLASTOMYCOSIS 1 0.0021
140 INFECTIVE ANEURYSM 1 0.0020
141 HERPES SIMPLEX 13 0.0020
142 MUSCLE CONTRACTIONS INVOLUNTARY 7 0.0020
143 DEVICE RELATED SEPSIS 4 0.0020
144 NEUTROPENIC COLITIS 4 0.0019
145 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
146 INTERLEUKIN LEVEL INCREASED 1 0.0018
147 VENA CAVA THROMBOSIS 3 0.0018
148 BRAIN SCAN ABNORMAL 1 0.0018
149 LEFT VENTRICULAR DYSFUNCTION 12 0.0018
150 LEUKAEMIA RECURRENT 3 0.0018
151 SUBCLAVIAN VEIN THROMBOSIS 2 0.0018
152 PANCREATITIS NECROTISING 4 0.0017
153 EJECTION FRACTION 1 0.0017
154 LYMPHOPROLIFERATIVE DISORDER 5 0.0017
155 GROIN ABSCESS 2 0.0017
156 ACIDOSIS HYPERCHLORAEMIC 1 0.0017
157 HYPOALBUMINAEMIA 13 0.0017
158 BLOOD CREATININE DECREASED 5 0.0016
159 LIP DISCOLOURATION 2 0.0016
160 GLUCOSE URINE PRESENT 2 0.0016
161 ABDOMINAL COMPARTMENT SYNDROME 1 0.0016
162 ABDOMINAL INFECTION 4 0.0016
163 HYPERCHLORAEMIA 1 0.0016
164 TUMOUR PAIN 2 0.0015
165 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
166 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
167 GLYCOSURIA 2 0.0015
168 HYPERURICAEMIA 6 0.0015
169 EXTRAVASATION 6 0.0015
170 BACTERAEMIA 17 0.0014
171 ALANINE AMINOTRANSFERASE ABNORMAL 3 0.0014
172 PELVIC FLUID COLLECTION 1 0.0014
173 MONOCYTE PERCENTAGE INCREASED 1 0.0014
174 MENINGITIS BACTERIAL 2 0.0014
175 ACUTE MYELOID LEUKAEMIA RECURRENT 3 0.0014
176 HYPERPHOSPHATAEMIA 3 0.0014
177 BLOOD CULTURE POSITIVE 4 0.0013
178 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
179 CREATINE KINASE INCREASED 1 0.0013
180 TIC 7 0.0013
181 MYELOSUPPRESSION 45 0.0012
182 DYSBIOSIS 1 0.0012
183 LEUKOCYTURIA 1 0.0012
184 LYMPHOCYTE COUNT DECREASED 21 0.0012
185 ENZYME LEVEL INCREASED 1 0.0012
186 PAPILLARY THYROID CANCER 2 0.0011
187 AREFLEXIA 3 0.0011
188 BLOOD MAGNESIUM INCREASED 1 0.0011
189 HEART TRANSPLANT 1 0.0011
190 VENOUS OCCLUSION 2 0.0011
191 SELECTIVE EATING DISORDER 1 0.0011
192 PREMATURE MENOPAUSE 1 0.0011
193 HYPOPHOSPHATAEMIA 8 0.0011
194 RENAL TUBULAR DISORDER 3 0.0011
195 ACUTE LYMPHOCYTIC LEUKAEMIA 3 0.0011
196 BRAIN STEM HAEMORRHAGE 1 0.0011
197 HYPOPROTEINAEMIA 2 0.0011
198 KLEBSIELLA BACTERAEMIA 1 0.0011
199 PCO2 DECREASED 1 0.0010
200 ACUTE MYELOID LEUKAEMIA 16 0.0010
201 TUMOUR LYSIS SYNDROME 9 0.0010
202 PYURIA 1 0.0010
203 ABDOMINAL TENDERNESS 5 0.0010
204 MESENTERIC VEIN THROMBOSIS 1 0.0010
205 HYPOGONADISM 1 0.0010
206 CATHETER RELATED INFECTION 1 0.0010
207 NEPHROPATHY TOXIC 11 0.0010
208 OSTEOLYSIS 2 0.0010
209 BLAST CELL COUNT INCREASED 1 0.0010
210 SYSTOLIC DYSFUNCTION 1 0.0009
211 HYDROCELE 1 0.0009
212 BACTERIAL SEPSIS 3 0.0009
213 CLAUSTROPHOBIA 1 0.0009
214 EJECTION FRACTION DECREASED 14 0.0009
215 MALNUTRITION 10 0.0009
216 MYOCARDIAL INJURY 1 0.0009
217 SARCOMA 1 0.0009
218 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
219 CARBON DIOXIDE DECREASED 1 0.0009
220 NEPHROGENIC DIABETES INSIPIDUS 1 0.0009
221 NEUTROPHIL COUNT DECREASED 35 0.0009
222 HYPOCHLORAEMIA 1 0.0009
223 HYPERTRIGLYCERIDAEMIA 5 0.0009
224 ESCHERICHIA BACTERAEMIA 2 0.0008
225 FEBRILE INFECTION 1 0.0008
226 LYMPHOPENIA 12 0.0008
227 STREPTOCOCCAL SEPSIS 1 0.0008
228 BLOOD UREA DECREASED 1 0.0008
229 HYPOCALCAEMIA 15 0.0008
230 FISTULA DISCHARGE 1 0.0008
231 NEUTROPENIA 107 0.0008
232 BLOOD BILIRUBIN ABNORMAL 1 0.0008
233 INFUSION SITE IRRITATION 1 0.0008
234 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
235 CARDIOPULMONARY FAILURE 3 0.0008
236 INTERCEPTED PRODUCT SELECTION ERROR 1 0.0008
237 PNEUMONIA FUNGAL 3 0.0008
238 PACKED RED BLOOD CELL TRANSFUSION 1 0.0008
239 ANION GAP INCREASED 1 0.0007
240 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
241 HAEMATOTOXICITY 7 0.0007
242 MUCOUS MEMBRANE DISORDER 1 0.0007
243 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0007
244 NEUTROPHIL COUNT ABNORMAL 2 0.0007
245 BREAST CANCER STAGE IV 2 0.0007
246 GRANULOCYTOPENIA 4 0.0007
247 NEUTROPENIC SEPSIS 5 0.0007
248 HYPOKALAEMIA 32 0.0007
249 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
250 ESCHERICHIA SEPSIS 2 0.0007
251 MUCOSAL INFLAMMATION 18 0.0007
252 PANCREATIC ENZYMES INCREASED 1 0.0007
253 EXCESSIVE EYE BLINKING 1 0.0007
254 CARDIOMYOPATHY 10 0.0007
255 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19 0.0007
256 PARAINFLUENZAE VIRUS INFECTION 1 0.0007
257 ORAL MUCOSAL ERYTHEMA 1 0.0006
258 HYPERTROPHIC CARDIOMYOPATHY 1 0.0006
259 BACTERIAL INFECTION 12 0.0006
260 HEPATIC FUNCTION ABNORMAL 24 0.0006
261 ELECTROCARDIOGRAM T WAVE ABNORMAL 1 0.0006
262 BONE MARROW FAILURE 13 0.0006
263 URINE KETONE BODY PRESENT 1 0.0006
264 OPTIC NERVE DISORDER 1 0.0006
265 ACUTE LEUKAEMIA 1 0.0006
266 TROPONIN I INCREASED 1 0.0006
267 MYOCARDIAL NECROSIS MARKER INCREASED 1 0.0006
268 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
269 SPLEEN DISORDER 1 0.0006
270 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 3 0.0006
271 BLOOD CHLORIDE INCREASED 1 0.0006
272 SKIN HYPOPIGMENTATION 1 0.0006
273 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
274 X-RAY ABNORMAL 1 0.0006
275 MONOCYTE COUNT INCREASED 2 0.0006
276 HIDRADENITIS 5 0.0005
277 PNEUMONIA KLEBSIELLA 1 0.0005
278 OTOTOXICITY 1 0.0005
279 STREPTOCOCCAL INFECTION 3 0.0005
280 PROTEIN TOTAL DECREASED 2 0.0005
281 LEUKAEMIA 5 0.0005
282 SEPTIC SHOCK 23 0.0005
283 BLOOD BICARBONATE DECREASED 1 0.0005
284 DEVICE RELATED INFECTION 8 0.0005
285 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
286 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
287 PULMONARY HAEMORRHAGE 4 0.0005
288 VENOUS THROMBOSIS 2 0.0005
289 HYPERAEMIA 1 0.0005
290 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
291 MUSCLE CONTRACTURE 1 0.0005
292 EYELID PAIN 1 0.0005
293 POST PROCEDURAL INFECTION 4 0.0005
294 VENTRICULAR TACHYCARDIA 8 0.0005
295 CAPILLARY LEAK SYNDROME 1 0.0005
296 SECOND PRIMARY MALIGNANCY 4 0.0005
297 NEUROGENIC BLADDER 1 0.0005
298 RENAL NEOPLASM 1 0.0005
299 ENTERITIS 3 0.0005
300 PERICARDIAL HAEMORRHAGE 1 0.0005
301 ASPERGILLUS INFECTION 3 0.0005
302 CHRONIC GASTRITIS 1 0.0004
303 SUSPECTED OFF LABEL USE 2 0.0004
304 DISTRIBUTIVE SHOCK 1 0.0004
305 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
306 ENCEPHALITIS 3 0.0004
307 ASPARTATE AMINOTRANSFERASE INCREASED 23 0.0004
308 NEUROLOGICAL DECOMPENSATION 1 0.0004
309 ALANINE AMINOTRANSFERASE INCREASED 26 0.0004
310 TRANSPLANT 1 0.0004
311 EOSINOPHIL COUNT DECREASED 1 0.0004
312 FUNGAL INFECTION 14 0.0004
313 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
314 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
315 LACUNAR INFARCTION 1 0.0004
316 PULSE ABNORMAL 1 0.0004
317 SINUS BRADYCARDIA 4 0.0004
318 STARING 1 0.0004
319 PRODUCT PACKAGING CONFUSION 1 0.0004
320 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
321 STEM CELL TRANSPLANT 1 0.0004
322 PLATELET DISORDER 1 0.0004
323 URINARY TRACT INFECTION BACTERIAL 1 0.0004
324 PATHOLOGICAL FRACTURE 2 0.0004
325 LACTOSE INTOLERANCE 1 0.0004
326 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
327 HYPERBILIRUBINAEMIA 4 0.0004
328 VENTRICULAR DYSFUNCTION 1 0.0004
329 THERAPY PARTIAL RESPONDER 6 0.0004
330 SERUM FERRITIN INCREASED 2 0.0004
331 WHITE BLOOD CELL DISORDER 1 0.0004
332 ABDOMINAL MASS 1 0.0004
333 WHITE BLOOD CELL COUNT DECREASED 40 0.0004
334 EMBOLISM 3 0.0004
335 GAMMA-GLUTAMYLTRANSFERASE INCREASED 8 0.0004
336 PANCYTOPENIA 20 0.0004
337 PROCTITIS 1 0.0004
338 PLATELET COUNT DECREASED 38 0.0004
339 ACUTE PULMONARY OEDEMA 2 0.0004
340 HAEMATEMESIS 9 0.0004
341 OXYGEN SATURATION ABNORMAL 1 0.0004
342 PNEUMATOSIS INTESTINALIS 1 0.0004
343 TUMOUR HAEMORRHAGE 1 0.0004
344 VOMITING PROJECTILE 1 0.0003
345 MYELODYSPLASTIC SYNDROME 5 0.0003
346 COMA SCALE ABNORMAL 1 0.0003
347 GASTROINTESTINAL NECROSIS 1 0.0003
348 NEUROTOXICITY 6 0.0003
349 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
350 STRIDOR 1 0.0003
351 BRAIN HERNIATION 1 0.0003
352 BONE MARROW DISORDER 1 0.0003
353 PORTAL HYPERTENSION 1 0.0003
354 HYPERCALCAEMIA 4 0.0003
355 INFUSION SITE EXTRAVASATION 2 0.0003
356 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
357 HYPONATRAEMIA 18 0.0003
358 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
359 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
360 PRODUCT PREPARATION ISSUE 2 0.0003
361 HYPOGAMMAGLOBULINAEMIA 2 0.0003
362 OTITIS MEDIA 1 0.0003
363 CORONAVIRUS INFECTION 2 0.0003
364 BK VIRUS INFECTION 1 0.0003
365 PNEUMONITIS 8 0.0003
366 NEUTROPHIL COUNT INCREASED 3 0.0003
367 PRODUCT USE ISSUE 55 0.0003
368 BLOOD CREATININE ABNORMAL 1 0.0003
369 HYPOMAGNESAEMIA 4 0.0003
370 TRANSFUSION 3 0.0003
371 MASS 4 0.0003
372 RIGHT VENTRICULAR FAILURE 2 0.0003
373 LIVER INJURY 7 0.0003
374 FIBRIN D DIMER INCREASED 1 0.0003
375 SEPSIS 31 0.0003
376 ASPIRATION 3 0.0003
377 BLOOD PHOSPHORUS DECREASED 1 0.0003
378 VIRAL INFECTION 9 0.0003
379 LEUKOENCEPHALOPATHY 1 0.0003
380 HAEMORRHAGE INTRACRANIAL 4 0.0003
381 LEUKOPENIA 13 0.0003
382 METASTASES TO LUNG 3 0.0003
383 ELECTROLYTE IMBALANCE 3 0.0003
384 CELLULITIS 13 0.0003
385 RHINOVIRUS INFECTION 1 0.0003
386 SPINAL CORD COMPRESSION 1 0.0003
387 POLYDIPSIA 1 0.0003
388 OESOPHAGEAL CANDIDIASIS 1 0.0003
389 THROMBOCYTOPENIA 28 0.0003
390 BLOOD DISORDER 2 0.0002
391 HYPERGLYCAEMIA 9 0.0002
392 RECURRENT CANCER 1 0.0002
393 HICCUPS 2 0.0002
394 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 2 0.0002
395 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
396 COAGULOPATHY 4 0.0002
397 HYPERPYREXIA 1 0.0002
398 FEBRILE BONE MARROW APLASIA 1 0.0002
399 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
400 POOR PERIPHERAL CIRCULATION 1 0.0002
401 UTERINE HAEMORRHAGE 1 0.0002
402 ABSCESS LIMB 1 0.0002
403 HEPATIC PAIN 1 0.0002
404 PRODUCT DISPENSING ISSUE 1 0.0002
405 ANURIA 2 0.0002
406 HEPATIC LESION 1 0.0002
407 OCULAR ICTERUS 1 0.0002
408 MONOPLEGIA 1 0.0002
409 VASCULAR DEVICE INFECTION 1 0.0002
410 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
411 CYSTITIS 7 0.0002
412 PNEUMONIA BACTERIAL 2 0.0002
413 ISCHAEMIA 1 0.0002
414 PROTEINURIA 4 0.0002
415 SEROTONIN SYNDROME 4 0.0002
416 GUILLAIN-BARRE SYNDROME 1 0.0002
417 NEOPLASM PROGRESSION 7 0.0002
418 IMMUNODEFICIENCY 3 0.0002
419 HYPOTONIA 2 0.0002
420 HYPERAMMONAEMIA 1 0.0002
421 ANAEMIA 38 0.0002
422 ERYSIPELAS 1 0.0002
423 KLEBSIELLA INFECTION 1 0.0002
424 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
425 DISEASE PROGRESSION 23 0.0002
426 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
427 VENTRICULAR EXTRASYSTOLES 2 0.0002
428 BLOOD LACTIC ACID INCREASED 1 0.0002
429 FULL BLOOD COUNT ABNORMAL 2 0.0002
430 ANAL ABSCESS 1 0.0002
431 OESOPHAGITIS 2 0.0002
432 WOUND INFECTION 2 0.0002
433 HEPATOTOXICITY 4 0.0002
434 NECROSIS 1 0.0002
435 INTRACRANIAL PRESSURE INCREASED 1 0.0002
436 BLOOD CALCIUM DECREASED 2 0.0002
437 SKIN TOXICITY 1 0.0002
438 GENERALISED ERYTHEMA 1 0.0002
439 MYOCARDIAL ISCHAEMIA 2 0.0002
440 MYOCARDITIS 2 0.0002
441 CARDIAC FAILURE 14 0.0002
442 NEOPLASM 2 0.0002
443 HERPES VIRUS INFECTION 1 0.0002
444 MOUTH SWELLING 1 0.0002
445 ENTEROCOLITIS 1 0.0002
446 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
447 HYPERLIPIDAEMIA 2 0.0002
448 PROTHROMBIN TIME PROLONGED 1 0.0002
449 RENAL IMPAIRMENT 14 0.0002
450 HEPATITIS B 1 0.0002
451 AGRANULOCYTOSIS 3 0.0002
452 PHARYNGITIS 2 0.0002
453 SWELLING OF EYELID 1 0.0002
454 INFUSION SITE SWELLING 1 0.0002
455 INFECTION 23 0.0002
456 PYREXIA 54 0.0002
457 HAEMOGLOBIN ABNORMAL 1 0.0002
458 DECREASED APPETITE 36 0.0002
459 HAEMORRHOIDS 3 0.0002
460 PANCREATITIS 8 0.0002
461 OFF LABEL USE 130 0.0001
462 METASTASES TO LYMPH NODES 1 0.0001
463 BLOOD BILIRUBIN INCREASED 4 0.0001
464 TACHYPNOEA 2 0.0001
465 ACUTE HEPATIC FAILURE 2 0.0001
466 INFARCTION 1 0.0001
467 RESPIRATION ABNORMAL 1 0.0001
468 HYPOTENSION 29 0.0001
469 HYPERTRANSAMINASAEMIA 1 0.0001
470 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
471 LYMPHADENOPATHY 5 0.0001
472 METASTASIS 1 0.0001
473 RED BLOOD CELL COUNT DECREASED 4 0.0001
474 UTERINE LEIOMYOMA 1 0.0001
475 ORAL DISORDER 1 0.0001
476 BLOOD PRESSURE DIASTOLIC DECREASED 1 0.0001
477 TRANSAMINASES INCREASED 3 0.0001
478 HYDRONEPHROSIS 1 0.0001
479 PANCREATITIS ACUTE 3 0.0001
480 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
481 PRODUCT USE IN UNAPPROVED INDICATION 33 0.0001
482 STOMATITIS 8 0.0001
483 HEPATOCELLULAR CARCINOMA 1 0.0001
484 TROPONIN INCREASED 1 0.0001
485 HYPERTHERMIA 1 0.0001
486 LIPASE INCREASED 1 0.0001
487 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
488 TORSADE DE POINTES 1 0.0001
489 DEHYDRATION 17 0.0001
490 BLOOD ALBUMIN DECREASED 1 0.0001
491 MUSCLE TIGHTNESS 2 0.0001
492 ENCEPHALOPATHY 3 0.0001
493 POLYURIA 1 0.0001
494 METASTASES TO BONE 2 0.0001
495 ESCHERICHIA INFECTION 1 0.0001
496 ACUTE CORONARY SYNDROME 1 0.0001
497 BREAST CANCER STAGE II 1 0.0001
498 HAEMODIALYSIS 1 0.0001
499 INFUSION SITE ERYTHEMA 1 0.0001
500 CANDIDA INFECTION 2 0.0001
501 FACIAL PARALYSIS 1 0.0001
502 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
503 PSEUDOMONAS INFECTION 1 0.0001
504 RESPIRATORY TRACT INFECTION 3 0.0001
505 PLEURAL EFFUSION 7 0.0001
506 ORTHOSTATIC HYPOTENSION 2 0.0001
507 HYPOXIA 4 0.0001
508 IMMUNOSUPPRESSION 1 0.0001
509 LUNG INFILTRATION 1 0.0001
510 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
511 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
512 TACHYCARDIA 10 0.0001
513 GASTROINTESTINAL INFECTION 1 0.0001
514 C-REACTIVE PROTEIN INCREASED 4 0.0001
515 RESPIRATORY FAILURE 8 0.0001
516 GRAND MAL CONVULSION 1 0.0001
517 APPENDICITIS 1 0.0001
518 COLITIS 4 0.0001
519 AFFECT LABILITY 1 0.0001
520 HYPERCHOLESTEROLAEMIA 1 0.0001
521 BONE PAIN 6 0.0001
522 PHARYNGEAL SWELLING 1 0.0001
523 HAEMATOCRIT DECREASED 2 0.0001
524 CYTOKINE RELEASE SYNDROME 2 0.0001
525 HEPATIC FAILURE 3 0.0001
526 TOXIC SKIN ERUPTION 1 0.0001
527 EMPHYSEMA 1 0.0001
528 PRODUCT ADMINISTRATION ERROR 2 0.0001
529 SUBARACHNOID HAEMORRHAGE 1 0.0001
530 BODY TEMPERATURE INCREASED 2 0.0001
531 DRUG ADMINISTRATION ERROR 3 0.0001
532 ABDOMINAL DISTENSION 10 0.0001
533 DRUG-INDUCED LIVER INJURY 3 0.0001
534 DERMATITIS 2 0.0001
535 FOLLICULITIS 1 0.0001
536 MOUTH ULCERATION 2 0.0001
537 SUDDEN DEATH 1 0.0001
538 BREAST PAIN 1 0.0001
539 PHARYNGITIS STREPTOCOCCAL 1 0.0001
540 PRODUCT PRESCRIBING ISSUE 2 0.0001
541 STAPHYLOCOCCAL INFECTION 3 0.0001
542 ORAL PAIN 2 0.0001
543 SKIN INFECTION 1 0.0001
544 FISTULA 1 0.0001
545 EYE INFECTION 1 0.0001
546 DELIRIUM 3 0.0001
547 EYELID OEDEMA 1 0.0001
548 ARRHYTHMIA 4 0.0001
549 CHOLECYSTITIS 1 0.0001
550 THYROID CANCER 1 0.0001
551 NO THERAPEUTIC RESPONSE 1 0.0001
552 RESPIRATORY DEPRESSION 1 0.0001
553 INTERCEPTED PRODUCT PREPARATION ERROR 1 0.0001
554 GENERALISED OEDEMA 1 0.0001
555 ILEUS 1 0.0001
556 TOOTH EXTRACTION 1 0.0001
557 INJECTION SITE DISCOLOURATION 1 0.0001
558 DERMATITIS ALLERGIC 1 0.0001
559 BRAIN OEDEMA 1 0.0001
560 VOMITING 37 0.0001
561 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
562 MYDRIASIS 1 0.0001
563 ANOREXIA 1 0.0001
564 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
565 ABDOMINAL PAIN 18 0.0001
566 INJECTION SITE INDURATION 1 0.0001
567 BEDRIDDEN 1 0.0001
568 GASTRITIS 2 0.0001
569 IMMUNE SYSTEM DISORDER 1 0.0001
570 NEOPLASM MALIGNANT 5 0.0001
571 NEUROPATHY PERIPHERAL 7 0.0001
572 DRUG TOXICITY 1 0.0001
573 RESPIRATORY DISTRESS 2 0.0001
574 ACUTE KIDNEY INJURY 11 0.0001
575 HAEMOPTYSIS 2 0.0001
576 COORDINATION ABNORMAL 1 0.0001
577 SINUS TACHYCARDIA 1 0.0001
578 GASTROENTERITIS 1 0.0001
579 HAEMOGLOBIN DECREASED 7 0.0001
580 ASCITES 2 0.0001
581 RENAL FAILURE 9 0.0001
582 PSYCHOTIC DISORDER 2 0.0001
583 PULMONARY MASS 1 0.0001
584 GASTROINTESTINAL DISORDER 6 0.0001
585 EPISTAXIS 5 0.0001
586 APHASIA 2 0.0001
587 OSTEOPENIA 1 0.0001
588 PNEUMONIA 21 0.0001
589 NERVOUS SYSTEM DISORDER 2 0.0001
590 BRAIN FOG 1 0.0001
591 CYANOSIS 1 0.0001
592 PRODUCT USE COMPLAINT 1 0.0001
593 DRUG INTERACTION 10 0.0001
594 PRODUCTIVE COUGH 3 0.0001
595 ABSCESS 1 0.0001
596 HYPOTHYROIDISM 2 0.0001
597 METABOLIC ACIDOSIS 2 0.0001
598 CARDIAC FAILURE CONGESTIVE 5 0.0001
599 DRUG INTOLERANCE 6 0.0001
600 NIGHT SWEATS 2 0.0001
601 BLOOD CREATININE INCREASED 4 0.0001
602 CHOLELITHIASIS 2 0.0001
603 OSTEONECROSIS 2 0.0001
604 MULTIPLE FRACTURES 1 0.0001
605 DRUG LEVEL INCREASED 1 0.0001
606 CYTOMEGALOVIRUS INFECTION 1 0.0001
607 BLOOD UREA INCREASED 1 0.0001
608 CHILLS 7 0.0001
609 PERICARDITIS 1 0.0001
610 HEMIPARESIS 1 0.0001
611 HEPATIC ENZYME INCREASED 4 0.0001
612 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
613 HYPERTENSION 12 0.0001
614 BRADYCARDIA 3 0.0001
615 GALLBLADDER DISORDER 1 0.0001
616 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
617 NAUSEA 43 0.0001
618 BLOOD SODIUM DECREASED 1 0.0001
619 GASTRIC ULCER 1 0.0001
620 CHOLESTASIS 1 0.0001
621 SEIZURE 6 0.0001
622 PRESCRIBED OVERDOSE 1 0.0001
623 DYSTONIA 1 0.0001
624 ATRIAL FIBRILLATION 5 0.0001
625 ORAL HERPES 1 0.0001
626 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
627 CONSTIPATION 11 0.0001
628 PRESCRIBED UNDERDOSE 1 0.0001
629 SYNCOPE 5 0.0000
630 INJURY ASSOCIATED WITH DEVICE 1 0.0000
631 CHEST DISCOMFORT 5 0.0000
632 PRODUCT PREPARATION ERROR 1 0.0000
633 INFLUENZA LIKE ILLNESS 4 0.0000
634 CARDIAC ARREST 4 0.0000
635 PULMONARY HYPERTENSION 1 0.0000
636 LIVER FUNCTION TEST INCREASED 1 0.0000
637 POOR QUALITY SLEEP 1 0.0000
638 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
639 MELAENA 1 0.0000
640 BLOOD PRESSURE DECREASED 3 0.0000
641 THERAPY NON-RESPONDER 2 0.0000
642 CHROMATURIA 1 0.0000
643 SKIN DISCOLOURATION 2 0.0000
644 SHOCK 1 0.0000
645 PERICARDIAL EFFUSION 1 0.0000
646 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
647 DYSPHAGIA 4 0.0000
648 DISEASE RECURRENCE 2 0.0000
649 COMA 2 0.0000
650 PRODUCT PRESCRIBING ERROR 1 0.0000
651 DIABETIC KETOACIDOSIS 1 0.0000
652 PRESYNCOPE 1 0.0000
653 AGITATION 3 0.0000
654 BRONCHITIS 3 0.0000
655 WEIGHT INCREASED 9 0.0000
656 CARDIOVASCULAR DISORDER 1 0.0000
657 HYPOPHAGIA 1 0.0000
658 DRUG RESISTANCE 1 0.0000
659 ANAPHYLACTIC SHOCK 1 0.0000
660 UNRESPONSIVE TO STIMULI 1 0.0000
661 DEAFNESS 1 0.0000
662 BREAST CANCER FEMALE 1 0.0000
663 DIARRHOEA 24 0.0000
664 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
665 TREATMENT FAILURE 3 0.0000
666 DIVERTICULITIS 1 0.0000
667 MENTAL STATUS CHANGES 1 0.0000
668 WOUND 1 0.0000
669 OXYGEN SATURATION DECREASED 2 0.0000
670 PAIN IN JAW 1 0.0000
671 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
672 HERPES ZOSTER 2 0.0000
673 URINARY INCONTINENCE 1 0.0000
674 BLOOD POTASSIUM DECREASED 1 0.0000
675 BREAST CANCER 3 0.0000
676 ASTHENIA 12 0.0000
677 PULMONARY EMBOLISM 3 0.0000
678 LACTIC ACIDOSIS 1 0.0000
679 DEEP VEIN THROMBOSIS 2 0.0000
680 ALOPECIA 6 0.0000
681 IMPAIRED HEALING 1 0.0000
682 INFUSION RELATED REACTION 2 0.0000
683 SKIN DISORDER 1 0.0000
684 URINARY RETENTION 1 0.0000
685 TOXICITY TO VARIOUS AGENTS 5 0.0000
686 CONDITION AGGRAVATED 9 0.0000
687 URINARY TRACT INFECTION 5 0.0000
688 HAEMATURIA 1 0.0000
689 HYPERKALAEMIA 1 0.0000
690 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
691 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
692 CEREBRAL HAEMORRHAGE 1 0.0000
693 DRUG EFFECT INCOMPLETE 1 0.0000
694 DYSURIA 1 0.0000
695 HALLUCINATION 2 0.0000
696 UNEVALUABLE EVENT 2 0.0000
697 DIABETES MELLITUS 2 0.0000
698 PLASMA CELL MYELOMA 1 0.0000
699 ABNORMAL BEHAVIOUR 1 0.0000
700 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
701 CONFUSIONAL STATE 4 0.0000
702 BLINDNESS 1 0.0000
703 OSTEOPOROSIS 1 0.0000
704 POLLAKIURIA 1 0.0000
705 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
706 CARDIO-RESPIRATORY ARREST 1 0.0000
707 RENAL FAILURE ACUTE 1 0.0000
708 HYPOACUSIS 1 0.0000
709 MUSCULOSKELETAL STIFFNESS 2 0.0000
710 PULMONARY OEDEMA 1 0.0000
711 VISION BLURRED 3 0.0000
712 OROPHARYNGEAL PAIN 2 0.0000
713 RENAL DISORDER 1 0.0000
714 COGNITIVE DISORDER 1 0.0000
715 COUGH 6 0.0000
716 DRUG INEFFECTIVE 28 0.0000
717 BLOOD GLUCOSE INCREASED 4 0.0000
718 GAIT DISTURBANCE 4 0.0000
719 RASH 9 0.0000
720 HYPOGLYCAEMIA 1 0.0000
721 LUNG DISORDER 1 0.0000
722 DYSPEPSIA 2 0.0000
723 HYPOAESTHESIA 3 0.0000
724 THERAPY CESSATION 1 0.0000
725 ERYTHEMA 4 0.0000
726 ILLNESS 2 0.0000
727 FATIGUE 15 0.0000
728 HAEMORRHAGE 2 0.0000
729 ECZEMA 1 0.0000
730 MUSCULOSKELETAL PAIN 1 0.0000
731 DEPRESSED MOOD 1 0.0000
732 RASH PRURITIC 1 0.0000
733 ANAPHYLACTIC REACTION 1 0.0000
734 MEDICATION ERROR 1 0.0000
735 BLISTER 1 0.0000
736 CONVULSION 1 0.0000
737 DYSPHONIA 1 0.0000
738 SURGERY 1 0.0000
739 THERAPEUTIC RESPONSE DECREASED 1 0.0000
740 ILL-DEFINED DISORDER 1 0.0000
741 DISCOMFORT 1 0.0000
742 CHEST PAIN 3 0.0000
743 HYPERSENSITIVITY 3 0.0000
744 LOSS OF CONSCIOUSNESS 2 0.0000
745 INSOMNIA 4 0.0000
746 HEADACHE 9 0.0000
747 BURNING SENSATION 1 0.0000
748 INJURY 1 0.0000
749 SLEEP DISORDER 1 0.0000
750 DYSPNOEA 8 0.0000
751 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
752 ANXIETY 4 0.0000
753 MOBILITY DECREASED 1 0.0000
754 UNDERDOSE 1 0.0000
755 BACK PAIN 3 0.0000
756 DEATH 11 0.0000
757 THROMBOSIS 1 0.0000
758 TREMOR 2 0.0000
759 URTICARIA 2 0.0000
760 CEREBROVASCULAR ACCIDENT 2 0.0000
761 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
762 ADVERSE DRUG REACTION 1 0.0000
763 NO ADVERSE EVENT 2 0.0000
764 WEIGHT DECREASED 3 0.0000
765 SOMNOLENCE 2 0.0000
766 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
767 FLUSHING 1 0.0000
768 INFLUENZA 1 0.0000
769 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
770 PALPITATIONS 1 0.0000
771 DIZZINESS 4 0.0000
772 PRURITUS 3 0.0000
773 HYPERHIDROSIS 1 0.0000
774 PSORIASIS 1 0.0000
775 MALAISE 3 0.0000
776 BLOOD PRESSURE INCREASED 1 0.0000
777 HOSPITALISATION 1 0.0000
778 PERIPHERAL SWELLING 1 0.0000
779 PARAESTHESIA 1 0.0000
780 ABDOMINAL DISCOMFORT 1 0.0000
781 COVID-19 1 0.0000
782 ABDOMINAL PAIN UPPER 1 0.0000
783 INCORRECT DOSE ADMINISTERED 1 0.0000
784 FEELING ABNORMAL 1 0.0000
785 PRODUCT DOSE OMISSION ISSUE 1 0.0000
786 PAIN IN EXTREMITY 1 0.0000
787 ARTHRALGIA 1 0.0000
788 PAIN 1 0.0000